BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20012752)

  • 1. The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.
    Steiner T; Kirchner H; Siebels M; Doehn C; Heynemann H; Varga Z; Rohde D; Schubert J; Jocham D; Stief C; Fornara P; Hofmann R; Loening S; Roigas J
    J Cancer Res Clin Oncol; 2010 Jun; 136(6):905-10. PubMed ID: 20012752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
    Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
    Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study of brain metastasis of renal cell carcinoma.
    Harada Y; Nonomura N; Kondo M; Nishimura K; Takahara S; Miki T; Okuyama A
    Eur Urol; 1999 Sep; 36(3):230-5. PubMed ID: 10450008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma.
    Vogl UM; Bojic M; Lamm W; Frischer JM; Pichelmayer O; Kramer G; Haitel A; Kitz K; Harmankaya K; Zielinski CC; Schmidinger M
    BMC Cancer; 2010 Sep; 10():480. PubMed ID: 20819239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review.
    Kierney PC; van Heerden JA; Segura JW; Weaver AL
    Ann Surg Oncol; 1994 Jul; 1(4):345-52. PubMed ID: 7850534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma.
    Bölükbas S; Kudelin N; Eberlein M; Fisseler-Eckhoff A; Schirren J
    Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
    Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
    Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Therapy for Renal Cell Carcinoma.
    Joshi R; Rawal S
    JNMA J Nepal Med Assoc; 2015; 53(198):83-8. PubMed ID: 26994026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment of metastases in renal cell carcinoma].
    Langer W; Hofmockel G; Theiss M; Frohmüller H
    Urologe A; 1997 Nov; 36(6):548-51. PubMed ID: 9487591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
    Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
    Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.
    Molina AM; Tickoo SK; Ishill N; Trinos MJ; Schwartz LH; Patil S; Feldman DR; Reuter VE; Russo P; Motzer RJ
    Am J Clin Oncol; 2011 Oct; 34(5):454-9. PubMed ID: 21127411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-adjusted proposal for >60 months follow up after surgical treatment of organ-confined renal cell carcinoma according to life expectancy.
    Frees SK; Kamal MM; Nestler S; Levien PM; Bidnur S; Brenner W; Thomas C; Jaeger W; Thüroff JW; Roos FC
    Int J Urol; 2019 Mar; 26(3):385-390. PubMed ID: 30588677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence.
    Grüllich C; Vallet S; Hecht C; Duensing S; Hadaschik B; Jäger D; Hohenfellner M; Pahernik S
    Urol Oncol; 2016 May; 34(5):238.e9-17. PubMed ID: 26739671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic relevance of metastatic renal cell carcinoma in the head and neck: An evaluation of 22 cases in 671 patients.
    Lieder A; Guenzel T; Lebentrau S; Schneider C; Franzen A
    Int Braz J Urol; 2017; 43(2):202-208. PubMed ID: 27649110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
    Assouad J; Banu E; Brian E; Pham DN; Dujon A; Foucault C; Riquet M
    Eur J Cardiothorac Surg; 2008 May; 33(5):794-8. PubMed ID: 18304831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
    Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
    J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
    Shuch B; La Rochelle JC; Wu J; Klatte T; Riggs SB; Kabbinavar F; Belldegrun AS; Pantuck AJ
    Cancer; 2008 Sep; 113(6):1324-31. PubMed ID: 18661529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-modal treatment for metastatic renal cancer: the role of surgery.
    Russo P
    World J Urol; 2010 Jun; 28(3):295-301. PubMed ID: 20364382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrectomy in metastatic renal cell carcinoma.
    Campbell SC; Flanigan RC; Clark JI
    Curr Treat Options Oncol; 2003 Oct; 4(5):363-72. PubMed ID: 12941196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.